Dimitrios Iliopoulos

Company: Athos Therapeutics

Job title: Chief Executive Officer

Seminars:

Developing Novel IBD Therapeutics Using Artificial Intelligence & Machine Learning 2:30 pm

Utilizing artificial intelligence and computational modelling to identify enzyme based novel drug targets Harnessing artificial intelligence to identify novel biomarkers of IBD to better inform trial design and patient subgroup Leveraging machine learning to improve IBD data analysisRead more

day: Day Two

Panel Discussion: Assessing the Most Promising Advances in IBD Biomarkers 2:45 pm

This is a session dedicated to evaluating the current use, future potential and limitations in a variety of not-yet clinically used biomarkers to get peer insights on the future of biomarkers for IBD and to discuss next steps in the field required for future advances. Approaches to be discussed: Utilizing metabolomics to profile IBD at…Read more

day: Day One